Affiliation:
1. U.O. Neurology IV, Neuroimmunology and Neuromuscular Diseases Unit. Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy
2. Department of Neurosciences, Biomedicine and Movement Sciences, Section of Clinical Neurology University of Verona Verona Italy
Abstract
AbstractWe aimed to verify whether the immune system may represent a source of potential biomarkers for the stratification of immune‐mediated necrotizing myopathies (IMNMs) subtypes. A group of 22 patients diagnosed with IMNM [7 with autoantibodies against signal recognition particle (SRP) and 15 against 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme A reductase (HMGCR)] and 12 controls were included. A significant preponderance of M1 macrophages was observed in both SRP+ and HMGCR+ muscle samples (p < 0.0001 in SRP+ and p = 0.0316 for HMGCR+), with higher values for SRP+ (p = 0.01). Despite the significant increase observed in the expression of TLR4 and all endosomal Toll‐like receptors (TLRs) at protein level in IMNM muscle tissue, only TLR7 has been shown considerably upregulated compared to controls at transcript level (p = 0.0026), whereas TLR9 was even decreased (p = 0.0223). Within IMNM subgroups, TLR4 (p = 0.0116) mRNA was significantly increased in SRP+ compared to HMGCR+ patients. Within IMNM group, only IL‐7 was differentially expressed between SRP+ and HMGCR+ patients, with higher values in SRP+ patients (p = 0.0468). Overall, innate immunity represents a key player in pathological mechanisms of IMNM. TLR4 and the inflammatory cytokine IL‐7 represent potential immune biomarkers able to differentiate between SRP+ and HMGCR+ patients.
Subject
Immunology,Immunology and Allergy
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献